SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported) January 27, 2000
DIALYSIS CORPORATION OF AMERICA
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 0-8527 59-1757642
- ---------------------------- ----------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
27 Miller Avenue, Lemoyne, Pennsylvania 17043
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (717) 730-6164
--------------
Item 5. Other Events.
The Company has loaned its parent, Medicore, Inc., $1,500,000 at an
interest rate of 10% per annum for one year through January 26, 2001. The
loan may be increased up to an additional $500,000. The financing was
provided for its parent's establishment of a new division which invests in
Linux software system companies. The parent's initial investment is a 6%
interest in The Linux Fund, a private holding company which has established
and is using the parent's funding to acquire equity positions in Linux
software system companies.
The Linux Fund has a 50%-owned subsidiary, The Linux Fund IPO.com, which
will provide a website facility for the Linux software companies in which it
has invested to effect direct public offerings at such time as they decide to
effect a public offering of their securities under a Dutch Auction system,
which allows potential investors the ability to bid for securities of initial
public offerings at prices for which they would like to purchase the
securities. The remaining 50% ownership of The Linux Fund IPO.com is held
by MainStreet IPO.com, Inc., a private company with which the Company has a
proposed merger. MainStreet has established a website for companies to
effect direct public offerings under a Dutch Auction process, and is
currently in discussions with the Securities and Exchange Commission as to
whether its proposed operations require broker-dealer registration or might
otherwise require restructuring.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(a) Financial Statements of Businesses Acquired
Not Applicable
(b) Pro Forma Financial Information
Not Applicable
(c) Exhibits
(10) Material Contracts
10.1 Promissory Note from Medicore, Inc. to the Company for
$1,500,000 dated January 27, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DIALYSIS CORPORATION OF AMERICA
/s/ Thomas K. Langbein
By:---------------------------------
THOMAS K. LANGBEIN, Chairman
of the Board and Chief Executive
Officer
Dated: February 10, 2000